Literature DB >> 3015012

Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells.

P Toltzis, A S Huang.   

Abstract

Ribavirin at 200 micrograms/ml inhibited vesicular stomatitis virus (VSV) growth in Chinese hamster ovary (CHO) cells by 2.5 logs. To determine the mechanism of this inhibition, viral macromolecular synthesis was examined. VSV primary transcription remained unaffected, but overall VSV RNA synthesis decreased by 40 to 60%. When ribavirin was added 1.5 h after infection, inhibition of progeny production was partially lost, indicating that the antiviral effect was on an early stage after primary transcription. Inhibition of RNA polymerization by premature chain termination was not evident. Viral translation, on the other hand, was reduced by 95% with an inhibition of every protein species. Furthermore, viral RNA synthesized in the presence of ribavirin did not translate well in an in vitro translation system. In contrast, uninfected CHO cells treated with ribavirin showed a greater sensitivity in RNA synthesis than in protein synthesis. This suggests that the cellular translational machinery was not directly affected. Short-term treatment of cells resulted in negligible toxicity, but after 24 h there was marked alteration of cellular integrity. These results, taken together with data on other viruses, suggest that in the presence of ribavirin, dysfunctional VSV mRNA was synthesized, resulting in its failure to be translated. The selective antiviral effects of ribavirin and its relative lack of toxicity for host cells may be predicted on the basis of mRNA turnover and the requirements for de novo functional mRNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015012      PMCID: PMC180493          DOI: 10.1128/AAC.29.6.1010

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells.

Authors:  J N Zullo; B H Cochran; A S Huang; C D Stiles
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

2.  Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules.

Authors:  A S Huang; D Baltimore; M Stampfer
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

3.  Inhibition of inosinate dehydrogenase by metabolites of 2-beta-D-ribofuranosyl thiazole-4-carboxamide.

Authors:  R Kuttan; R K Robins; P P Saunders
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

4.  5'-terminal structure of poliovirus polyribosomal RNA is pUp.

Authors:  M J Hewlett; J K Rose; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

5.  Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.

Authors:  V Knight; S Z Wilson; D W Alling; R V Moore; R M Longoria
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

6.  Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1969-08       Impact factor: 5.103

7.  Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis.

Authors:  S K Wray; B E Gilbert; M W Noall; V Knight
Journal:  Antiviral Res       Date:  1985-02       Impact factor: 5.970

8.  Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro.

Authors:  S K Wray; B E Gilbert; V Knight
Journal:  Antiviral Res       Date:  1985-02       Impact factor: 5.970

9.  Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Authors:  C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

10.  Ribavirin aerosol treatment of influenza B virus infection.

Authors:  H W McClung; V Knight; B E Gilbert; S Z Wilson; J M Quarles; G W Divine
Journal:  JAMA       Date:  1983-05-20       Impact factor: 56.272

View more
  12 in total

1.  Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.

Authors:  Andrea Rivas-Aravena; Eva Vallejos-Vidal; Marcelo Cortez-San Martin; Felipe Reyes-Lopez; Mario Tello; Patricia Mora; Ana María Sandino; Eugenio Spencer
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

2.  The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment.

Authors:  Dong-Hoon Chung; Åke Västermark; Jeremy V Camp; Ryan McAllister; Susanna K Remold; Yong-Kyu Chu; Carl Bruder; Colleen B Jonsson
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

3.  5'-Phospho-RNA Acceptor Specificity of GDP Polyribonucleotidyltransferase of Vesicular Stomatitis Virus in mRNA Capping.

Authors:  Minako Ogino; Tomoaki Ogino
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

4.  Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.

Authors:  Guido Wollmann; Justin C Paglino; Patrick R Maloney; Sebastian A Ahmadi; Anthony N van den Pol
Journal:  Virology       Date:  2014-11-21       Impact factor: 3.616

5.  High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).

Authors:  William E Severson; Michael McDowell; Subramaniam Ananthan; Dong-Hoon Chung; Lynn Rasmussen; Melinda I Sosa; E Lucile White; James Noah; Colleen B Jonsson
Journal:  J Biomol Screen       Date:  2008-09-23

6.  Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin.

Authors:  Nirav R Shah; Amanda Sunderland; Valery Z Grdzelishvili
Journal:  PLoS One       Date:  2010-06-22       Impact factor: 3.240

7.  Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription.

Authors:  P Toltzis; K O'Connell; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

8.  Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.

Authors:  Dong-Hoon Chung; Yanjie Sun; William B Parker; Jeffrey B Arterburn; Al Bartolucci; Colleen B Jonsson
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

9.  Ribavirin causes error catastrophe during Hantaan virus replication.

Authors:  William E Severson; Connie S Schmaljohn; Ali Javadian; Colleen B Jonsson
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus.

Authors:  Myung Jin Lee; Kye-Hyung Kim; Jongyoun Yi; Su Jin Choi; Pyoeng Gyun Choe; Wan Beom Park; Nam Joong Kim; Myoung-Don Oh
Journal:  Korean J Intern Med       Date:  2016-11-30       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.